相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Analysis of Different Definitions of Amyloid-β Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer
M. Mila-Aloma et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
Sanka Amadoru et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
Marta Mila-Aloma et al.
ALZHEIMERS & DEMENTIA (2020)
CSF biomarkers in Olmsted County Evidence of 2 subclasses and associations with demographics
C. Argonde Van Harten et al.
NEUROLOGY (2020)
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
Gemma Salvado et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
Valeria Lifke et al.
CLINICAL BIOCHEMISTRY (2019)
Subthreshold amyloid and its biological and clinical meaning Long way ahead
Gerard N. Bischof et al.
NEUROLOGY (2019)
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
Renaud La Joie et al.
ALZHEIMERS & DEMENTIA (2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Isabelle Bos et al.
ALZHEIMERS & DEMENTIA (2019)
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
Marta Mila-Aloma et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
Courtney L. Sutphen et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Subthreshold Amyloid Predicts Tau Deposition in Aging
Stephanie L. Leal et al.
JOURNAL OF NEUROSCIENCE (2018)
Memory decline accompanies subthreshold amyloid accumulation
Susan M. Landau et al.
NEUROLOGY (2018)
18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
Christopher C. Rowe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study
Clifford R. Jack et al.
LANCET NEUROLOGY (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid
Tobias Bittner et al.
ALZHEIMERS & DEMENTIA (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Antoine Leuzy et al.
BRAIN (2016)
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
Sebastian Palmqvist et al.
BRAIN (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Amyloid deposition in younger adults is linked to episodic memory performance
Gerard N. Bischof et al.
NEUROLOGY (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
Jon B. Toledo et al.
BRAIN (2015)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Biobanking of CSF: International standardization to optimize biomarker development
Charlotte E. Teunissen et al.
CLINICAL BIOCHEMISTRY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Brain β-amyloid load approaches a plateau
Clifford R. Jack et al.
NEUROLOGY (2013)
The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma
Carl P. C. Chen et al.
EXPERIMENTAL GERONTOLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months
Catherine Chiu et al.
FLUIDS AND BARRIERS OF THE CNS (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid β-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas
Juan Fortea et al.
BIOLOGICAL PSYCHIATRY (2011)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau et al.
NEUROBIOLOGY OF AGING (2011)
Aging affects choroidal proteins involved in CSF production in Sprague-Dawley rats
C Masseguin et al.
NEUROBIOLOGY OF AGING (2005)
分享论文
